Skip to main content
Log in

Enhanced expression of mRNA for insulin-like growth factor-1 in post-burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Hypertrophic scarring (HSc) which frequently develops in patients following severe thermal injury is characterized by accumulation of extracellular matrix (ECM) proteins including type I and type III collagen. In this study, we examined the presence and quantity of IGF-1 mRNA transcripts in post-burn HSc. The results of dot blot experiments showed a 77.5% (100±8.15 vs 177.5±19, p<0.01) increase in expression of IGF-1 IIIRNA in HSc tissue relative to normal dermis obtained from the same patients. A Northern blot analysis confirmed the specificity of the IGF-1 cDNA. This cDNA visualized four different transcripts with apparent sizes of 7.0, 3.9, 1.8 and 1.0 kb, similar to those previously reported. The possible fibrogenic role of IGF-1 was examined by analyzing the effect of this growth factor on the expression of mRNA for the pro α1(I) chain of type I procollagen and the pro α1(III) chain of type III procollagen in dermal fibroblasts. IGF-1 increased the expression of these transcripts as early as 6 h and the effect was maximal at 24 h. Quantitative analysis by densitometry showed a 149 and 166% increase in pro α1(I) and pro α1(III) mRNA after 24 h of IGF-1 treatment, respectively. This effect seems to be specific as the abundance of mRNA for the pro α2(I) chain of type I procollagen or TIMP-II was unchanged. When another 4 strains of dermal fibroblasts were treated with IGF-1, a significant increase (16.94±1.13 vs 10.87±1.79, p<0.01, N=4) in the expression of type I procollagen mRNA was found. This was consistent with a significant increase in collagen production, as measured by hydroxyproline in conditioned medium (2.04±0.3 ng/1000 cells vs 1.35±0.4 ng/1000 cells, p<0.01, N=4). The effects of IGF-1 were temporary, since removal of IGF-1 from media caused a reduction in expression of type I procollagen mRNA to its basal level within 48 h.

Enhanced expression of IGF-1 mRNA in post-burn HSc tissues and the potentially fibrogenic effects of this growth factor on dermal fibroblasts, suggest that it could contribute to the accumulation of type I and type III collagen found in many fibroproliferative disorders such as HSc.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Scott PG, Ghahary A, Chambers MM, Tredget EE: Biological basis of hypertrophic scarring. In: Advances in Structural Biology, JAI Press Inc, Greenwich, Connecticut, 1994, Vol 3: pp 157–202

    Google Scholar 

  2. Bitterman PB, Henke CA: Fibroproliferative disorders. Chest 99: 81s-84s, 1991

    Google Scholar 

  3. Linares HA, Kischer CW, Dobrkovsky K, Larson DL: The histotypic organization of the hypertrophic scar in humans. J Invest Dermatol 59: 323–331, 1972

    Google Scholar 

  4. Ghahary A, Shen YJ, Gong Y, Scott PG, Tredget EE: Enhanced expression of mRNA for transforming growth factor β1, type 1, type III procollagen in human post-burn hypertrophicscar tissues. J Lab Clin Med 122: 465–473, 1993

    Google Scholar 

  5. Ghahary A, Shen YJ, Scott PG, Tredget EE: Expression of fibronectin mRNA in hypertrophic and normal dermal tissues andin vitro regulation by interferon alpha-2b. Wound Repair and Regeneration 1(3): 166–174, 1993

    Google Scholar 

  6. Ghahary A, Scott PG, Malhotra S, Friedland UA, Harrop AR, Forsyth NL, Tredget EE: Differential expression of type I and type III procollagen mRNA in human hypertrophic burn fibroblasts. Biomed Lett 47: 169–184, 1992

    Google Scholar 

  7. Baird A, Mormede P, Bohlen P: Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggest its identity with macrophage derived growth factor. Biochem Biophys Res Comm 126: 358–364, 1985

    Google Scholar 

  8. Shimokado K, Raines EW, Madtes DK, Barrett TB, Benditt AP, Ross R: A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 43: 277–286, 1985

    Google Scholar 

  9. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB: Expression and secretion of type B transforming growth factor by activated human macrophage. Proc Natl Acad Sci USA 84: 6020–6024, 1987

    Google Scholar 

  10. Rappolee, DA, Mark D, Banda MJ, Werb Z: Wound macrophages express TGF-α and other growth factorsin vivo: analysis of mRNA phenotyping. Science 241: 708–712, 1988

    Google Scholar 

  11. Wahl LM, Whal SM: Inflammation. In: Cohen, Diegelmann, Lindblad (eds). Wound Healing. W.B. Saunders, Philadelphia, PA, 1992, pp 40–53

    Google Scholar 

  12. McGee G, Davidson JM, Buckley A, Sommer A, Woodword SC, Aquino AM, Barbour R, Dermetriou AA: Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res 45: 145–153, 1988

    Google Scholar 

  13. Schultz GS, White M, Mitchell R, Brown G, Lynch J, Twadzik DR, Todaro GJ, Epithelial wound healing enhanced by transforming growth factor. Science 235: 350–352, 1987

    Google Scholar 

  14. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B: Some recent advances in the chemistry and biology of transforming grwoth factor. J Cell Biol 105: 1039–1045, 1987

    Google Scholar 

  15. Lynch SE, Nixon JC, Colvin RB, Antoniades HN: Role of platelet-derived growth factor in wound healing-synergistic effects with other growth factors. Proc Natl Acad Sci USA 84: 7696–7700, 1987

    Google Scholar 

  16. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B: A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β. Cell 52: 405–414, 1988

    Google Scholar 

  17. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche S, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS: Transforming growth factor B rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formationin vitro. Proc Natl Acad Sci USA 83: 4167–4171, 1986

    Google Scholar 

  18. Pierce GF, Mustoe TA, Lingelbach J, Maskakowsi VR, Griffin GL, Senior RM. Deuel TF: Platelet derived-growth factor and transforming growth factor inducein vivo andin vitro tissue repair activities by unique mechanisms. J Cell Biol 429–440, 1989

  19. Morgan CJ, Pledger WJ: Fibroblast proliferation. In: Cohen, Diegelmann, Lindblad (eds). Wound Healing. W.B. Saunders, Philadelphia, PA, 1992, pp 63–73

    Google Scholar 

  20. Rockwell WB, Cohen IK, Ehrlich HP: Keloids and hypertrophic scars comprehensive review. Plast Reconstr Surg 84: 827–837, 1989

    Google Scholar 

  21. Nakano T, Scott PG: Purification and characterization of a gelatinase produced by fibroblasts from human gingiva. Biochem Cell Biol 64: 387–393, 1986

    Google Scholar 

  22. Uitto J, Booth BA, Polak KI: Collagen biosynthesis by human skin fibroblasts: Isolation and further characterization of type I and type III procollagen synthesized in culture. Biochim Biophys Acta 624: 545–561, 1980

    Google Scholar 

  23. Chirgwin JMt Pryzbyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochem 18: 5294–5299, 1979

    Google Scholar 

  24. Thomas PS: Hybridization of denatured RNA and small DNA fragments transferred tonitrocellulose. Proc Natl Acad Sci USA 77: 5201–5205, 1980

    Google Scholar 

  25. Tredget EE, Shen Y, Forsyth N, Smith C, Scott PG, Ghahary A: The effect of interferon alpha-2b on hypertrophic scar fibroblastsin vitro. Wound Repair and Regeneration 1(3): 156–165, 1993

    Google Scholar 

  26. Murphy LJ, Bell GJ, Friesen HG: Tissue distribution of insulin-like growth factor-1 and II mRNA in adult rats. Endocrinol 120: 1279–1282, 1987

    Google Scholar 

  27. Sikbergeld A, Lazar L, Erster B, Keret R, Tepper R, Laron Z: Serum growth hormone binding protein activity in healthy neonates, children, and young adults-correlation with age, height and weight. Clin Endocrinol 31: 295–303, 1989

    Google Scholar 

  28. Spencer EM, Skover G, Hunt TK: Growth factors and other agents of wound healing. In: E. Barbul, E. Pines, M. Caldwell, T.K. Hunt (eds): Biological and Clinical Implication. Liss: NY, 1988, pp 103–116

    Google Scholar 

  29. Gartner MH, Benson JD, Caldwell MD: Insulin-like growth factors I and II expressioninthe healingwound. J Surg Res 52: 389–394, 1992

    Google Scholar 

  30. Hunt TK, Hussain Z: Wound microenvironment. In: Cohen, Diegelmann, Lindblad (eds). Wound Healing. W.B. Saunders, Philadelphia, PA, 1992, pp 274–281

    Google Scholar 

  31. Russel WE, Van-Wyk JJ, Pledger WJ: Proc Natl Acad Sci USA 81: 2388–2392, 1984

    Google Scholar 

  32. Clemmons DR, Van Wyk JJ. Somatomedins: Physiological control and effects on cell proliferation. In: R. Baserga (ed.). Handbook of Experimental Pharmacology. Springer-Verlag, New York, 1981, pp 161–164

    Google Scholar 

  33. Narayanan AS, Meyers DF, Page RC, Welgus HG: Action of mammalian collagenase on the type I trimer collagen. Collagen Rel Res 4: 289–296, 1984

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghahary, A., Shen, Y.J., Nedelec, B. et al. Enhanced expression of mRNA for insulin-like growth factor-1 in post-burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem 148, 25–32 (1995). https://doi.org/10.1007/BF00929499

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00929499

Key words

Navigation